Advances in coronary heart disease surgery in Latin America

Circulation

Volumn 115, Issue 9, 2007, Pages 1147-1153

  Gurfinkel, Enrique P ^a   Lernoud, Veronica S ^a   Laguens, Ruben P ^a   Favaloro, Roberto R ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Cardiopulmonary bypass; Coronary disease; Epidemiology; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; VASCULOTROPIN 165; ANTITHROMBOCYTIC AGENT; CARDIOPLEGIC AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ARTERIAL CONDUIT; ARTERY SURGERY; ARTICLE; ATHEROSCLEROSIS; CARDIOPLEGIA; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DISEASE SEVERITY; GENETIC TRANSFECTION; HEALTH ECONOMICS; HEALTH STATUS; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MEDICAL LITERATURE; MEDICINE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SOUTH AND CENTRAL AMERICA; SURGICAL TECHNIQUE; THROMBOSIS; ADULT; AGE; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; ECONOMICS; FEMALE; GENE THERAPY; HEART INFARCTION; HYPERLIPIDEMIA; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; OBESITY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESTENOSIS; REVIEW; RISK FACTOR; SOCIOECONOMICS; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHEROSCLEROSIS; CARDIOPLEGIC SOLUTIONS; COMBINED MODALITY THERAPY; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES MELLITUS; DIET; FEMALE; FIBRINOLYTIC AGENTS; GENE THERAPY; HUMANS; HYPERLIPIDEMIAS; LATIN AMERICA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; REOPERATION; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33947579411     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.623595     Document Type: Article

References (50)

1. Hurst GW. A view from the South. In: Favaloro RG, ed. Clinical Essays on the Heart. Vol 2. New York, NY: McGraw Hill Book Company; 1984.
2. Espinola-Klein C, Rupprecht HJ, Erbel R, Nafe B, Brennecke R, Meyer J. Ten-year outcome after coronary angioplasty in patients with singlevessel coronary artery disease and comparison with the results of the Coronary Artery Surgery Study (CASS). Am J Cardiol. 2000;85:321-326.
3. Gabe E, Abud JA, Macchia A, Raffaelli H, Dulbecco E, Machain A, Favaloro RR. Resultados hospitalarios en cirugía de revascularización miocárdica. Predoctores clínicos de complicaciones. Pren Med Argent. 2003;90:394-400.
4. Berman M, Stamler A, Sahar G, Georghiou GP, Sharoni E, Brauner R, Medalion B, Vidne BA, Kogan A. Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg. 2006;81:537-540.
5. Resultados del Censo de Argentina del 2000. Instituto Nacional de Estadística y Censos (INDEC). Available at http://www.indec.mecon.ar. Accessed February 2, 2006.
6. Favaloro RG. Surgical Treatment of Coronary Arteriosclerosis. Cleveland Clinic Foundation. Baltimore, Md: The Williams and Wilkins Company; 1970.
7. Carvalho de Noronha J, Travassos C, Martins M, Campos MR, Maia P, Panezzuti R. Volume and quality of care in coronary artery bypass grafting in Brazil. Cad Saude Publica, Rio de Janeiro. 2003;19:1781-1789.
8. Milani R, Brofman P, Varela A, Moutinho JA, Guimaraes M, Pantarolli R, Barbosa L, Barbosa A, Pina G, Maia F. Total myocardium revascularization without extracorporeal circulation: five-year experience. Braz J Cardiovasc Surg. 2005;20:52-57.
9. Mancini B, Nani S, Núñez OT, Devoto M, Damonte M, Michel D, Rivas R. El uso de hipolipemiantes ¿produce una reducción de la morbimortalidad perioperatoria en cirugía cardíaca? Rev Arg Cir Cardiovasc. 2004;2:97-104.
10. Navia D, Vrancic M, Vaccarino G, Piccinini F, Iparraguirre E, Casas M, Thierer J. Off-pump coronary artery bypass with multiple arterial conduits. Braz J Cardiovasc Surg. 2005;20:39-45.
11. Anderson FA, Dabbous O, Goldberg R, Gurfinkel E. Persistent failure to close the age and gender gap in the use of evidence-base therapies in acute coronary syndromes: temporal trends (1999-2003) in the Global Registry of Acute Coronary Events. Circulation. 2004;110(suppl III):III-798. Abstract.
12. Aschner P, Cañete F. Implementing national diabetes programs in Latin America. Diabetes Voice. 2001;4:46.
13. Navia D, Vaccarino G, Vrancic M, Piccinini F, Iparraguirre E, Albertal J, Seguira E, Thierer J. Resultado terapéutico de la cirugía coronaria. Análisis de la evolución alejada. Estudio SEGUIR. Rev Argent Cardiol. 2003;71:275-281.
14. Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman SG; Canadian Acute Coronary Syndromes Registry Investigators. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol. 2005;96:913-916.
15. Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM). Available at http://www.clinicaltrials.gov. Accessed February 2, 2006.
16. Perez M, Casas JP, Cubillos-Garzon LA, Serrano NC, Silva F, Morillo CA, Lopez-Jaramillo P. Using waist circumference as a screening tool to identify Colombian subjects at cardiovascular risk. Eur J Cardiovasc Prev Rehabil. 2003;10:328-335.
17. Velasquezu Oa, Hernando Santos C, Hernando Orjuela L, Caicedo A, Nestor Sandoval R, Nuñez F, Correa A Jr, Jimenez M, Jaramillo C, Abello M. Revascularización miocárdica sin circulación extracorpórea ¿Hay disminución de morbilidad y mortalidad? Rev Colombiana de Cardiol. 2002;9:365-372.
18. Garcia-Castillo A, Jerjes-Sánchez C, Martinez BP, Azpiri-Lopez JR, Autrey CA, Martinez SC, Ramos CMA, Llamas G, Martinez SJ, Treviño AJ. Registro Mexicano de Síndromes coronarios Agudos. Arch Cardiol Mex. 2005;75(suppl 1):6-19.
19. Irarrazaval MJ, Munoz MC, Garayar B. Coronary surgery: 20 years of follow-up. Rev Med Chil. 1998;126:63-74.
20. De Souza e Silva NA. Performance e Tecnologia em Medicina. O caso da revascularizacao miocardica por cirugia ou por angioplastia. Universidad Federal do Rio de Janeiro. Revista da SOCERJ. 2005;18:123-130.
21. Gurfinkel E, Bozovich G, Dabbous O, Mautner B, Anderson F. Socioeconomic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. Thromb J. 2005;3:22.
22. Castro Neto JV, Chaccur P, de Carvalho RA, Staico R, Albertal M, Farran J, Moreira LFP, Lisboa LA, Oliveira SA, Paulista PP. Coronary artery bypass grafting with composite grafts: comparison of blood flow to the left coronary artery with the conventional technique. Braz J Cardiovasc Surg. 2004;19:365-371.
23. Whitaker JF, Passos PHC, Ramalho GM, Muniz AJ, Castro Pimentel R, Lopes Lourdes JB, Borges AF, Miana AA. The use of the radial artery as the second choice for arterial graft in patients over 70 years of age. Braz J Cardiovasc Surg. 2005;20:58-62.
24. Weinschelbaum E, Macchia A, Caramutti VM, Machain HA, Raffaelli HA, Favaloro MR, Favaloro RR, Dulbecco EA, Abud JA, De Laurentiis M, Gabe ED. Myocardial revascularization with radial and mammary arteries: initial and mid-term results. Ann Thorac Surg. 2000;4:1378-1383.
25. Weinschelbaum ED, Macchia A, Caramutti VM, Machain HA, Raffaelli HA, Favaloro MR, Favaloro RR, Dulbecco EA, Abud JA, de Laurentis M, Gabe ED. Cirugía de revascularización coronaria con conductos arteriales. Técnica, resultados y seguimiento a cuatro años en 1,023 pacientes consecutivos. Rev Esp Cardiol. 2000;53:179-188.
26. Cuenca J, Bonome C. Cirugía coronaria sin circulación extracorpórea y otras técnicas mínimamente invasivas. Rev Esp Cardiol. 2005;58:1335-1348.
27. Buffolo E. Myocardial revascularization without extracorporeal circulation. Arq Bras Cardiol. 2005;85:287-288.
28. Buffolo E, Branco JN, Gerola LR, Aguiar LF, Teles CA, Palma JH, Catani R. Off-pump myocardial revascularization: critical analysis of 23 years' experience in 3866 patients. Ann Thorac Surg. 2006;81:85-89.
29. Weinschelbaum EE, Machain A, Raffaelli HA, Caramutti VM, Favaloro MR, Dulbecco EA, Danielo R. Off-pump coronary operation at the Favaloro Foundation: results in 264 patients. Ann Thorac Surg. 2000;70:1030-1033.
30. Herreros J. Coronary surgery. Developments in the last decade: indications and results. Rev Esp Cardiol. 2005;58:1107-1116.
31. Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR Jr, Bardsley WT, Pluth JR, Wallace RB, Puga FJ, Orzulak TA, Pehler JM, Danielson GK, Schaff HV, Frye RL. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med. 1984;310:209-214.
32. Altman R, Rouvier J, Gurfinkel E. Oral anticoagulant treatment with and without aspirin. Thromb Haemost. 1995;74:506-510.
33. Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie AG. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation. 1996;94:2113-2116.
34. Gohlke H, Gohlke-Barwolf C, Sturzenhofecker P, Gornandt L, Ritter B, Reichelt M, Buchwalsky R, Schmuziger M, Roskamm H. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: a prospective, randomized study. Circulation. 1981;64:II22-II27.
35. Rothlin ME, Pfluger N, Speiser K, Goebel N, Krayenbuhl HP, Steinbrunn W, Turina M, Senning A. Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion. Eur Heart J. 1985;6:168-175.
36. Eritsland J, Arnesen H. Secondary prophylaxis after myocardial infarction, bypass surgery and percutaneous coronary intervention. Tidsskr Nor Laegeforen. 2004;124:946-949.
37. Koster A, Spiess B, Chew DP, Krabatsch T, Tambeur L, DeAnda A, Hetzer R, Kuppe H, Smedira NG, Lincoff AM. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2004;93:356-359.
38. Sander GE, Wilklow FE, Giles TD. Heart failure in diabetes mellitus: causal and treatment considerations. Minerva Cardioangiologica. 2004;52:491-503.
39. White FC, Bloor CM, McKirnan MD, Carroll SM. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol. 1998;85:1160-1168.
40. Chilian WM. Coronary microcirculation in health and disease. Circulation. 1997;95:522-528.
41. Krams R, Kofflard MJM, Duncker DJ, Von Birgelen C, Carlier S, Kliffen M, ten Cate FJ, Serruys PW. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation. 1998;97:230-233.
42. Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol. 1998;30:2531-2540.
43. Strauer BE, Schwartzkopff B, Kelm M. Assessing the coronary circulation in hypertension. J Hypertens. 1998;16:1221-1233.
44. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004;109:1121-1126.
45. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part I: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004;109:146-149.
46. Crottogini A, Meckert PC, Vera Janavel G, Lascano E, Negroni J, Del Valle H, Dulbecco E, Werba P, Cuniberti L, Martinez V, de Lorenzi A, Telayna J, Mele A, Fernandez JL, Marangunich L, Criscuolo M, Capogrossi MC, Laguens R. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther. 2003;14:1307-1318.
47. Vera Janavel G, Crottogini A, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M, Fernandez N, Bercovich A, Criscuolo M, Melo C, Laguens R. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Therapy. 2006;13:1133-1142.
48. 165 gene transfer. Gene Ther. 2002;9:1676-1681.
49. Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, Del Valle H, Cuniberti L, Martinez V, Dulbecco E, Melo C, Fernandez N, Criscuolo M, Crottogini A. Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med. 2004;6:222-227.
50. 165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One Trial. J Am Coll Cardiol. 2005;45:982-988.